Atea Pharmaceuticals (AVIR) EPS (Basic) (2019 - 2026)
Atea Pharmaceuticals (AVIR) posted quarterly EPS (Basic) of -$0.57 for Q1 2026, down 42.57% year-over-year from -$1.0 in Q1 2025, and down 4.21% quarter-over-quarter from -$0.55 in Q4 2025.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) EPS (Basic) (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.57 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 42.57% year-over-year to -$0.57; the TTM figure through Mar 2026 stood at -$2.14 (down 30.68% YoY), while the FY2025 annual figure was -$1.94, up 2.76% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.57, down from -$0.55 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.1 in Q3 2022, with the low at -$0.75 in Q1 2024.
- The 5-year median for EPS (Basic) is -$0.43 (2023), against an average of -$0.44.
- Peak annual rise in EPS (Basic) reached 71.54% in 2022, while the deepest fall reached 2123.49% in 2022.
- Atea Pharmaceuticals' EPS (Basic) stood at -$0.41 in 2022, then slipped by 13.55% to -$0.47 in 2023, then grew by 15.24% to -$0.4 in 2024, then sank by 38.31% to -$0.55 in 2025, then declined by 4.21% to -$0.57 in 2026.
- Business Quant data shows AVIR's EPS (Basic) at -$0.57 in Q1 2026, -$0.55 in Q4 2025, and -$0.53 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Atea Pharmaceuticals | 465.89 Mn | 465.89 Mn | - | -0.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.41 |
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.53 |
| Jun 30, 2025 | -0.44 |
| Mar 31, 2025 | -0.40 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.34 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -0.10 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.51 |
| Dec 31, 2021 | 1.41 |
| Sep 30, 2021 | -0.34 |